LINC00400: A Drug Target / Disease Biomarker (G100874159)

Target Name: LINC00400

NCBI ID: G100874159

LINC00400

Other Name(s): Long intergenic non-protein coding RNA 400 | long intergenic non-protein coding RNA 400

LINC00400: A Drug Target / Disease Biomarker

LINC00400 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell adhesion and has been shown to play a role in a variety of biological processes, including cancer progression, neurodegeneration, and development.

The LINC00400 gene was identified in the human genome using transcriptome sequencing technologies. It is located on chromosome 6 and has been shown to encode a protein that is involved in the regulation of cell adhesion and in the process of cell migration.

The protein encoded by LINC00400 is a member of the cadherin family, which is a well-known family of transmembrane proteins that are involved in cell-cell adhesion. Cadherins are made up of four transmembrane domains: an extracellular domain that is involved in cell adhesion, a transmembrane domain that spans the cell membrane, and two intracellular domains that are involved in the regulation of cell adhesion.

LINC00400 has been shown to play a role in the regulation of cell adhesion and in the process of cell migration. It is expressed in a variety of tissues and has been shown to be involved in the development and progression of cancer.

One of the most promising aspects of LINC00400 is its potential as a drug target. By blocking the function of LINC00400, it is possible to treat a variety of diseases that are caused by the regulation of cell adhesion, including cancer, neurodegeneration, and developmental disorders.

In addition to its potential as a drug target, LINC00400 also has potential as a biomarker. Its expression has been shown to be affected by a variety of factors, including cancer treatment, neurodegeneration, and aging. By studying the expression of LINC00400, researchers may be able to develop new diagnostic tests for these diseases and monitor the effectiveness of potential treatments.

Overall, LINC00400 is a promising molecule that has the potential to be a drug target and biomarker. Further research is needed to fully understand its function and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 400

The "LINC00400 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00400 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets